ORTEXORTEX News
Tracking BNTX? Get live short interest, options flow, and signals on ORTEX.Sign up free →
BN

BioNTech SE (BNTX) short interest & options flow

NASDAQ

BNTX barely moved last week, down 0.2%, while closest peer MRNA rallied nearly 10% and the broader mRNA-adjacent group pushed higher across the board. The gap is sharpest when you line up the peer moves. Moderna gained close to 10% on the week. ARCT fell 15%, so the cohort is not uniformly bid, but BNTX's near-flat week looks distinctly muted against the…

Latest pulse8 Sept 2026

BNTX downgraded by BMO Capital to Market Perform from Outperform, price target cut to $105 from $128 (-18%), now trading below revised PT at $103.76.

$90.70+4.35% 1d+3.08% 1w-6.40% 1mClose: 4 Nov 2026
Cost to borrow
Low
Live CTB on ORTEX →
Availability
High
Live availability on ORTEX →
Market cap
$22.49B
Next earnings
2 Mar 2027
See the full picture on ORTEX →Live short interest, options flow, signals, 13F filings, and more.

Key data as of 5 Nov 2026

ORTEX chart of BioNTech SE (BNTX) share price and short interest (% of free float), six months to November 4, 2026

BNTX news and analysis

RSS

No long-form analysis yet for BNTX. Pulse alerts and the live data picture are available on ORTEX.

Open BNTX on ORTEX →

Want the live picture for BNTX?

Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for BNTX — free to start on ORTEX.

Sign up for free →Open BNTX on ORTEX